Among 50 male patients with SFTP, 43 were eligible.3 The Tapias score (0–6) was as follows: n = 3, 2 points; n = 7, 3 points; n = 13, 4 points; n = 18, 5 points; and n = 2, 6 points. Tapias score = 0 was not recorded. With a cutoff ≥ 3,3,4 40 patients (93%) were labeled as high risk for recurrence, and three (7%) were labeled as low risk. The Cox regression analysis was reanalyzed, exploring the value of Tapias score in predicting recurrence or death (Table 1). We registered at follow-up 12 recurrences (30%) in the high-risk group vs none in the low-risk group (P = .06), confirming the usefulness of the Tapias score as a predictor of recurrence. In addition, malignant pleural effusion and chest wall invasion significantly increased the risk of recurrence (P = .03 and .007, respectively). The completeness of resection was the only independent factor influencing the prognosis on multivariate analysis (P = .01).